Why the study?
Does statin therapy improve the achievement of target cholesterol <5 mmol/l in patients with CHD in primary care?
Cross-Sectional (n=300)
Yes
Does statin therapy improve the achievement of target cholesterol <5 mmol/l in patients with CHD in primary care?
Answers are grounded in this paper and cite their sources.
Despite proven benefits, secondary prevention of dyslipidemia in primary care remains suboptimal, with many CHD patients not receiving statins or receiving inadequate doses.
Management of hyperlipidaemia in patients with ischaemic heart disease is suboptimal despite the proven benefit of statin therapy. Significant improvement in management has been shown in the EUROASPIRE II study. It is unclear, however, whether such changes have also occurred in primary care. We aimed to evaluate the use of statin therapy by performing a cross-sectional survey of 300 patients with CHD aged >30 years from three general practices. A total of 249 (83%) of the 300 patients had their cholesterol measured and 141 (47%) were on statin therapy; 129 (43% of total) achieved a target cholesterol of <5 mmol/l, of whom 85 (64%) were on statin therapy. Of the remaining 120 patients whose cholesterol exceeded 5 mmol/l, 56 (47%) were on statin therapy Thus 60% (85/141) of those on statin therapy achieved adequate control compared with 40% (44/108) without statins (p<0.008). Those patients with CHD diagnosed on objective evidence were more likely to receive statin therapy (55.5%). Many patients with CHD are still not receiving appropriate secondary prevention. Those on statin therapy are more likely to achieve target levels <5 mmol/l. The average doses of statins vary and are lower than the evidence-based doses used in previous large-scale studies, which may help explain the persistence of failed treatment.
No takes yet. Share an insight, caveat, or question.
Wright et al. (2003) conducted a cross-sectional in Coronary heart disease (n=300). Statin therapy vs. No statin therapy was evaluated on Achieving target cholesterol of <5 mmol/l (p=<0.008).
Synapse has enriched 10 related papers. Consider them for comparative context: